Chikungunya: Acute fever, rash and debilitating arthralgias in a returning traveler from Haiti

Journal of Travel Medicine

Volumn 21, Issue 6, 2014, Pages 418-420

  Anderson, Kathryn B ^a   Pureza, Vincent ^a   Walker, Patricia F ^a,b,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c HEALTHPARTNERS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LIDOCAINE; METHYLPREDNISOLONE; MORPHINE; NAPROXEN; PARACETAMOL; SALSALATE; VIRUS RNA; GLUCOCORTICOID;

ADULT; ANTIBODY TITER; ARTHRALGIA; ARTICLE; CASE REPORT; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; DENGUE VIRUS; DIAPHORESIS; FATIGUE; FEMALE; FEVER; HAITI; HEADACHE; HUMAN; HYPERPIGMENTATION; LYMPHADENOPATHY; MACULOPAPULAR RASH; MALARIA; MOUTH ULCER; NAUSEA; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; TRAVEL; ACUTE DISEASE; CHIKUNGUNYA FEVER; COMPLICATION; EXANTHEMA; ISOLATION AND PURIFICATION; TREATMENT OUTCOME; TROPIC CLIMATE; VIROLOGY;

ACUTE DISEASE; ADULT; ARTHRALGIA; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; EXANTHEMA; FEMALE; GLUCOCORTICOIDS; HAITI; HUMANS; METHYLPREDNISOLONE; TRAVEL; TREATMENT OUTCOME; TROPICAL CLIMATE;

EID: 84964313191     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/jtm.12159     Document Type: Article

References (10)

1. Burt FJ, Rolph MS, Rulli NE, et al. Chikungunya: a re-emerging virus. Lancet 2012; 379:662-671.
2. Sissoko D, Moendandze A, Malvy D, et al. Seroprevalence and risk factors of chikungunya virus infection in Mayotte, Indian Ocean, 2005-2006: a population-based survey. PLoS One 2008; 3:e3066.
3. Queyriaux B, Simon F, Grandadam M, et al. Clinical burden of chikungunya virus infection. Lancet Infect Dis 2008; 8:2-3.
4. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 2007; 3:e201.
5. Centers for Disease Control and Prevention. Chikungunya in the Americas. Available at: http://www.cdc.gov/chikungunya/geo/americas.html. (Accessed 2014 Jul 3)
6. Morens DM, Fauci AS. Chikungunya at the door—déjá vu all over again? N Engl J Med 2014, July 16. DOI: 10.1056/NEJMp1408509
7. Van Bortel W, Dorleans F, Rosine J, et al. Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe. Euro Surveill 2014; 19 pii: 20759.
8. Lee VJ, Chow A, Zheng X, et al. Simple clinical and laboratory predictors of Chikungunya versus dengue infections in adults. PLoS Negl Trop Dis 2012; 6:e1786.
9. Hochedez P, Canestri A, Guihot A, et al. Management of travelers with fever and exanthema, notably dengue and chikungunya infections. Am J Trop Med Hyg 2008; 78:710-713.
10. Nimmannitya S, Halstead SB, Cohen SN, Margiotta MR. Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg 1969; 18:954-971.